This information was published on 2026-08-12T11:42:37 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2683789 (IR 1930966) |
| (220) |
06 Jul 2026
|
| (300) |
KR, 15 Jan 2026, 4020260009195
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of cancer; medicines for human purposes. |
| (540) | ONKLEMA |
| (550) | Word |
| (730) |
CELLTRION, INC.
|
Find out more about publications on the About page.